Meet the expert...
Principal at Dark Horse Consulting
Sara has spent over 11 years in the field of cell & gene therapy, the majority of which has been focused on supporting companies and academic labs with CMC development considerations. She joined Dark Horse Consulting in 2016 where her range encompasses managing cross-continental technology transfer, cGMP manufacturing process development, Design of Experiments, raw material risk assessment, leading root cause analysis, along with driving CMC-regulatory filings and strategy. During her time at DHC she has been fortunate enough to work with over 60 clients on over 65 different products that originate from at least 9 different countries.